市場調査レポート
商品コード
1426142

デジタルバイオマーカーの世界市場:見通しと予測(2024年~2029年)

Digital Biomarkers Market - Global Outlook & Forecast 2024-2029

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 352 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
デジタルバイオマーカーの世界市場:見通しと予測(2024年~2029年)
出版日: 2024年02月15日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 352 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルバイオマーカーの市場規模は、2023年に24億9,000万米ドルとなり、2023年から2029年にかけて22.86%のCAGRで成長すると予測されています。

デジタル化されたバーチャル臨床研究の台頭は、世界のデジタルバイオマーカー市場における重要な動向であり、遠隔モニタリング技術の進歩と、より効率的で患者中心の臨床試験の必要性がその背景にあります。この動向により、患者参加と実データ収集が促進され、さまざまなヘルスケア用途でのデジタルバイオマーカーの開発と検証が加速しています。

世界のデジタルバイオマーカー市場における顕著な動向は、ベンダー間の提携やパートナーシップの増加です。このようなパートナーシップは、専門知識、技術、リソースを組み合わせ、イノベーションを促進し、さまざまなヘルスケア分野でのデジタルバイオマーカーの応用を拡大し、最終的には患者とヘルスケアシステムに利益をもたらします。

高齢化と慢性疾患の増加は、市場の極めて重要な促進要因となっています。高齢者人口が拡大し、慢性疾患が蔓延するにつれて、遠隔モニタリング、早期発見、個別化された健康管理を可能にするデジタルソリューションに対するニーズが高まっており、デジタルバイオマーカーは現代ヘルスケアに不可欠な要素となっています。

デジタルバイオマーカーが可能にする遠隔患者モニタリングの進歩は、リアルタイムで患者データを提供し、早期介入を強化し、慢性疾患管理を最適化することで、ヘルスケアに革命をもたらしています。この技術主導のシフトは、より個別化され、効率的でコスト効率の高いヘルスケアソリューションを提供するため、世界のデジタルバイオマーカー市場の成長を促進しています。

当レポートでは、世界のデジタルバイオマーカー市場について調査し、市場の概要とともに、製品タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査対象・調査範囲

第2章 重要考察

第3章 市場の概要

第4章 イントロダクション

第5章 市場機会と動向

第6章 市場成長の促進要因

  • 高齢化人口の増加と慢性疾患の罹患率
  • 遠隔患者モニタリングの進歩
  • デジタルヘルスの文化の成長と外来ケアへの移行
  • ワイヤレスおよびウェアラブルデジタルモニタリング技術の利用が拡大

第7章 市場抑制要因

  • データセキュリティとプライバシーに関する懸念
  • 低い導入率
  • 規制標準化の欠如

第8章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第9章 製品タイプ

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • ウェアラブルとセンサー
  • モバイルアプリケーションとソフトウェア

第10章 用途

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • 心臓病
  • 呼吸器科
  • 神経科
  • その他

第11章 臨床実践

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • 診断
  • 監視
  • 予後
  • 予防
  • その他

第12章 エンドユーザー

  • 市場のスナップショットと成長促進要因
  • 市場概要
  • ヘルスケア企業
  • 医療機関
  • その他

第13章 地域

第14章 北米

第15章 欧州

第16章 アジア太平洋

第17章 ラテンアメリカ

第18章 中東・アフリカ

第19章 競合情勢

  • 競合の概要
  • 市場シェア分析

第20章 主要な企業プロファイル

  • ACTIGRAPH
  • ALIVECOR
  • AMGEN
  • BIOGEN
  • KONEKSA HEALTH

第21章 その他の著名なベンダー

  • ADHERIUM
  • AURAL ANALYTICS
  • BIOFOURMIS
  • CLARIO
  • EMPATICA
  • FEEL THERAPEUTICS
  • GERO.AI
  • IXICO
  • OBVIO HEALTH
  • OWKIN
  • PRECORDIOR
  • RESAPP HEALTH
  • ROCKLEY PHOTONICS
  • SONDE HEALTH
  • VIVOSENSE

第22章 レポートの概要

第23章 定量的な概要

第24章 付録

図表

List Of Exhibits

LIST OF EXHIBITS

  • EXHIBIT 1 MARKET SIZE CALCULATION APPROACH (2023)
  • EXHIBIT 2 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
  • EXHIBIT 3 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
  • EXHIBIT 4 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
  • EXHIBIT 5 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
  • EXHIBIT 6 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
  • EXHIBIT 7 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 8 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 9 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 10 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 11 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 12 IMPACT OF RISE IN DIGITIZED VIRTUAL CLINICAL RESEARCH
  • EXHIBIT 13 IMPACT OF INCREASING FOCUS ON DRUG DEVELOPMENT USING DIGITAL BIOMARKERS
  • EXHIBIT 14 BENEFITS OF DIGITAL BIOMARKERS IN DRUG DEVELOPMENT
  • EXHIBIT 15 IMPACT OF EXPANDING APPLICATIONS OF DIGITAL BIOMARKERS IN MENTAL HEALTH
  • EXHIBIT 16 IMPACT OF GROWING COLLABORATIONS & PARTNERSHIPS AMONG VENDORS
  • EXHIBIT 17 IMPACT OF RISE IN AGING POPULATION & PREVALENCE OF CHRONIC DISEASES
  • EXHIBIT 18 IMPACT OF ADVANCES IN REMOTE PATIENT MONITORING
  • EXHIBIT 19 IMPACT OF GROWING CULTURE OF DIGITAL HEALTH & SHIFT TOWARD OUTPATIENT CARE
  • EXHIBIT 20 IMPACT OF GROWING USE OF WIRELESS & WEARABLE DIGITAL MONITORING TECHNOLOGIES
  • EXHIBIT 21 IMPACT OF DATA SECURITY & PRIVACY CONCERNS
  • EXHIBIT 22 IMPACT OF LOW ADOPTION RATE
  • EXHIBIT 23 IMPACT OF LACK OF REGULATORY STANDARDIZATION
  • EXHIBIT 24 GLOBAL DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 25 FIVE FORCES ANALYSIS (2023)
  • EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT TYPE (2023 & 2029)
  • EXHIBIT 27 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 28 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 29 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 30 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 31 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 32 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 33 INCREMENTAL GROWTH BY APPLICATION (2023 & 2029)
  • EXHIBIT 34 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 35 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 36 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 37 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 38 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 39 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 40 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 41 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 42 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 43 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 44 INCREMENTAL GROWTH BY CLINICAL PRACTICE (2023 & 2029)
  • EXHIBIT 45 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 46 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 47 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 49 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 50 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 51 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 53 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 55 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 56 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 57 INCREMENTAL GROWTH BY END-USER (2023 & 2029)
  • EXHIBIT 58 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 59 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 60 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 61 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 62 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 63 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 64 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 65 GLOBAL OTHER DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY (2023 & 2029)
  • EXHIBIT 67 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 68 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 69 NORTH AMERICA DIGITAL BIOMARKERS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
  • EXHIBIT 70 NORTH AMERICA DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 71 DIGITAL BIOMARKERS MARKET IN NORTH AMERICA 2023-2029 ($ MILLION)
  • EXHIBIT 72 INCREMENTAL GROWTH IN NORTH AMERICA (2023 & 2029)
  • EXHIBIT 73 US DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 74 DIGITAL BIOMARKERS MARKET IN CANADA 2023-2029 ($ MILLION)
  • EXHIBIT 75 EUROPE DIGITAL BIOMARKERS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
  • EXHIBIT 76 EUROPE DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 77 DIGITAL BIOMARKERS MARKET IN EUROPE 2023-2029 ($ MILLION)
  • EXHIBIT 78 INCREMENTAL GROWTH IN EUROPE (2023 & 2029)
  • EXHIBIT 79 DIGITAL BIOMARKERS MARKET IN GERMANY 2023-2029 ($ MILLION)
  • EXHIBIT 80 UK DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 81 DIGITAL BIOMARKERS MARKET IN FRANCE 2023-2029 ($ MILLION)
  • EXHIBIT 82 DIGITAL BIOMARKERS MARKET IN ITALY 2023-2029 ($ MILLION)
  • EXHIBIT 83 DIGITAL BIOMARKERS MARKET IN SPAIN 2023-2029 ($ MILLION)
  • EXHIBIT 84 DIGITAL BIOMARKERS MARKET IN RUSSIA 2023-2029 ($ MILLION)
  • EXHIBIT 85 DIGITAL BIOMARKERS MARKET IN NETHERLANDS 2023-2029 ($ MILLION)
  • EXHIBIT 86 APAC DIGITAL BIOMARKERS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
  • EXHIBIT 87 APAC DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 88 DIGITAL BIOMARKERS MARKET IN APAC 2023-2029 ($ MILLION)
  • EXHIBIT 89 INCREMENTAL GROWTH IN APAC (2023 & 2029)
  • EXHIBIT 90 DIGITAL BIOMARKERS MARKET IN JAPAN 2023-2029 ($ MILLION)
  • EXHIBIT 91 DIGITAL BIOMARKERS MARKET IN CHINA 2023-2029 ($ MILLION)
  • EXHIBIT 92 DIGITAL BIOMARKERS MARKET IN INDIA 2023-2029 ($ MILLION)
  • EXHIBIT 93 DIGITAL BIOMARKERS MARKET IN SOUTH KOREA 2023-2029 ($ MILLION)
  • EXHIBIT 94 DIGITAL BIOMARKERS MARKET IN AUSTRALIA 2023-2029 ($ MILLION)
  • EXHIBIT 95 LATIN AMERICA DIGITAL BIOMARKERS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
  • EXHIBIT 96 LATIN AMERICA DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 97 DIGITAL BIOMARKERS MARKET IN LATIN AMERICA 2023-2029 ($ MILLION)
  • EXHIBIT 98 INCREMENTAL GROWTH IN LATIN AMERICA (2023 & 2029)
  • EXHIBIT 99 DIGITAL BIOMARKERS MARKET IN BRAZIL 2023-2029 ($ MILLION)
  • EXHIBIT 100 DIGITAL BIOMARKERS MARKET IN MEXICO 2023-2029 ($ MILLION)
  • EXHIBIT 101 DIGITAL BIOMARKERS MARKET IN ARGENTINA 2023-2029 ($ MILLION)
  • EXHIBIT 102 DIGITAL BIOMARKERS MARKET IN COLOMBIA 2023-2029 ($ MILLION)
  • EXHIBIT 103 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
  • EXHIBIT 104 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 105 DIGITAL BIOMARKERS MARKET IN MIDDLE EAST & AFRICA 2023-2029 ($ MILLION)
  • EXHIBIT 106 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2023 & 2029)
  • EXHIBIT 107 DIGITAL BIOMARKERS MARKET IN TURKEY 2023-2029 ($ MILLION)
  • EXHIBIT 108 DIGITAL BIOMARKERS MARKET IN SAUDI ARABIA 2023-2029 ($ MILLION)
  • EXHIBIT 109 UAE DIGITAL BIOMARKERS MARKET 2023-2029 ($ MILLION)
  • EXHIBIT 110 DIGITAL BIOMARKERS MARKET IN SOUTH AFRICA 2023-2029 ($ MILLION)
  • EXHIBIT 111 VENDORS OFFERING DIGITAL BIOMARKERS: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 112 VENDORS OFFERING COMMERCIAL DIGITAL BIOMARKERS: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 113 KEY CAVEATS

List Of Tables

LIST OF TABLES

  • TABLE 1 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY: MARKET SIZE 2023-2029 ($ MILLION)
  • TABLE 2 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE: MARKET SIZE 2023-2029 ($ MILLION)
  • TABLE 3 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION: MARKET SIZE 2023-2029 ($ MILLION)
  • TABLE 4 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE: MARKET SIZE 2023-2029 ($ MILLION)
  • TABLE 5 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER: MARKET SIZE 2023-2029 ($ MILLION)
  • TABLE 6 COMPARISON OF DIGITAL BIOMARKERS AND TRADITIONAL BIOMARKERS
  • TABLE 7 EXAMPLES OF COMPANY'S DIGITAL BIOMARKERS FOCUSING ON CHRONIC CONDITIONS
  • TABLE 8 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 9 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 10 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 11 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 12 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 13 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 14 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 15 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 16 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 17 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 18 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 19 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 20 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 21 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 22 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 23 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 24 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 25 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 26 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 27 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 28 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 29 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 30 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 31 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 32 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 33 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 34 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 35 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 36 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 37 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 38 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 39 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 40 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 41 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 42 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 43 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 44 EUROPE DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 45 EUROPE DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 46 EUROPE DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 47 EUROPE DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 48 EUROPE DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 49 EUROPE DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 50 EUROPE DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 51 EUROPE DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 52 APAC DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 53 APAC DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 54 APAC DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 55 APAC DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 56 APAC DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 57 APAC DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 58 APAC DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 59 APAC DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 60 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 61 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 62 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 63 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 64 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 65 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 66 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 67 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 68 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 69 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 70 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 72 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 73 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 74 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 75 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 76 ACTIGRAPH: MAJOR PRODUCT OFFERINGS
  • TABLE 77 ALIVECOR: MAJOR PRODUCT OFFERINGS
  • TABLE 78 AMGEN: MAJOR PRODUCT OFFERINGS
  • TABLE 79 BIOGEN: MAJOR PRODUCT OFFERINGS
  • TABLE 80 KONEKSA HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 81 ADHERIUM: MAJOR PRODUCT OFFERINGS
  • TABLE 82 AURAL ANALYTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 83 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
  • TABLE 84 CLARIO: MAJOR PRODUCT OFFERINGS
  • TABLE 85 EMPATICA: MAJOR PRODUCT OFFERINGS
  • TABLE 86 FEEL THERAPEUTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 87 GERO.AI: MAJOR PRODUCT OFFERINGS
  • TABLE 88 IXICO: MAJOR PRODUCT OFFERINGS
  • TABLE 89 OBVIO HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 90 OWKIN: MAJOR PRODUCT OFFERINGS
  • TABLE 91 PRECORDIOR: MAJOR PRODUCT OFFERINGS
  • TABLE 92 RESAPP HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 93 ROCKLEY PHOTONICS: MAJOR PRODUCT OFFERINGS
  • TABLE 94 SONDE HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 95 VIVOSENSE: MAJOR PRODUCT OFFERINGS
  • TABLE 96 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 97 GLOBAL DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 98 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 99 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 100 EUROPE DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 101 EUROPE DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 102 APAC DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 103 APAC DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 104 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 105 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 106 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 ($ MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY PRODUCT TYPE 2023-2029 (%)
  • TABLE 108 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 109 GLOBAL DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 110 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 111 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 112 EUROPE DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 113 EUROPE DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 114 APAC DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 115 APAC DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 116 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 117 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 118 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 119 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 120 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 121 GLOBAL DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 122 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 123 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 124 EUROPE DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 125 EUROPE DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 126 APAC DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 127 APAC DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 128 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 129 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 130 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 ($ MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY CLINICAL PRACTICE 2023-2029 (%)
  • TABLE 132 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 133 GLOBAL DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 134 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 135 NORTH AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 136 EUROPE DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 137 EUROPE DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 138 APAC DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 139 APAC DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 140 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 141 LATIN AMERICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 142 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET BY END-USER 2023-2029 (%)
  • TABLE 144 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 145 GLOBAL DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 146 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 147 GLOBAL WEARABLES & SENSORS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 148 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 149 GLOBAL MOBILE APPLICATION & SOFTWARE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 150 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 151 GLOBAL CARDIOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 152 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 153 GLOBAL PULMONOLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 154 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 155 GLOBAL NEUROLOGY DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 156 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 157 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 158 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 159 GLOBAL DIAGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 160 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 161 GLOBAL MONITORING DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 162 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 163 GLOBAL PROGNOSTIC DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 164 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 165 GLOBAL PREDICTIVE DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 166 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 167 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 168 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 169 GLOBAL HEALTHCARE COMPANIES DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 170 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 171 GLOBAL HEALTHCARE PROVIDERS DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 172 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 173 GLOBAL OTHER DIGITAL BIOMARKERS MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 174 CURRENCY CONVERSION (2017-2023)
目次
Product Code: ARZ231208

The global digital biomarkers market was valued at USD 2.49 billion in 2023 and is expected to grow at a CAGR of 22.86% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Rise in Digitized Virtual Clinical Research

The rise in digitized virtual clinical research is a significant trend in the global digital biomarkers market, driven by advances in remote monitoring technologies and the need for more efficient, patient-centric clinical trials. This trend allows for greater patient participation and real-world data collection, accelerating the development and validation of digital biomarkers for various healthcare applications.

Increasing Focus on Drug Development Using Digital Biomarkers

The global digital biomarkers market is witnessing a notable trend with an increasing focus on drug development. Pharmaceutical and biotech companies are leveraging digital biomarkers to enhance clinical trials, improve patient recruitment, and expedite the development of new therapies, harnessing the power of real-time data for evidence-based decision-making. This trend represents a significant shift towards more efficient and data-driven drug development processes, benefiting patients and the pharmaceutical industry.

Expanding Applications of Digital Biomarkers in Mental Health

The digital markers are increasingly used to monitor and analyze behavioral patterns, providing valuable insights into stress levels, mood fluctuations, and sleep quality, supporting the proactive management of mental health conditions. This trend reflects the broader shift towards personalized, data-driven mental healthcare.

Growing Collaborations & Partnerships Among Vendors

A prominent trend in the global digital biomarkers market is the increasing number of vendor collaborations and partnerships. These partnerships combine expertise, technologies, and resources, fostering innovation and expanding the application of digital biomarkers across various healthcare sectors, ultimately benefiting patients and healthcare systems.

Rise in Aging Population & Prevalence of Chronic Diseases

The aging population and the increasing prevalence of chronic diseases have become pivotal drivers of the market. As the elderly demographic expands and chronic conditions become more widespread, there is a growing need for digital solutions that enable remote monitoring, early detection, and personalized health management, making digital biomarkers an essential component of modern healthcare.

Advancements in Remote Patient Monitoring

Advancements in remote patient monitoring, enabled by digital biomarkers, are revolutionizing healthcare by providing real-time patient data, enhancing early intervention, and optimizing chronic disease management. This technology-driven shift is fueling the growth of the global digital biomarkers market as it offers more personalized, efficient, and cost-effective healthcare solutions.

Growing Culture of Digital Health & Shift Toward Outpatient Care

The growing culture of digital health is fostering a shift toward outpatient care, where patients can monitor and manage their health remotely. This shift is a driving force behind the global digital biomarkers market, as digital biomarkers enable real-time patient monitoring and data-driven healthcare, improving outcomes and reducing the burden on traditional healthcare facilities.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The global digital biomarkers market by product type is segmented into wearables & sensors and mobile applications & software. The wearables & sensors segment dominated the segmental share in 2023 and is expected to register the highest segmental CAGR in the global digital biomarkers market during the forecast period. Wearable devices include smartwatches, fitness trackers, and other sensor-equipped devices that collect continuous health data, such as heart rate, activity levels, and sleep patterns. Wearables are a primary source of physiological data, providing insights into various health parameters. They are crucial in remote patient monitoring, clinical trials, and preventive healthcare. Sensors measure biomarkers in bodily fluids, offering insights into various health conditions. They find applications in diagnostics, disease monitoring, and research studies.

Mobile and software applications designed for smartphones and tablets enable users to monitor and manage their health. These systems often incorporate wearable devices and sensors to collect continuous patient vital signs and health status data. They support the management of chronic diseases and post-operative care. They contribute to disease management and wellness initiatives.

Segmentation by Product Type

  • Wearables & Sensors
  • Mobile Application & Software

INSIGHTS BY APPLICATION

The global digital biomarkers market by application is segmented into cardiology, pulmonology, and neurology. In 2023, cardiology accounted for a significant segmental share of the global market, followed by pulmonology, neurology, and others. Cardiology has witnessed significant advancements, leading to a better understanding of cardiovascular diseases (CVDs) and improved diagnostic and treatment options. Digital biomarkers have recently emerged as a revolutionary tool transforming the cardiology landscape. Digital biomarkers are measurable, physiological, behavioral, or molecular data that can be collected and analyzed using digital health technologies. These biomarkers offer new ways to diagnose, monitor, and treat CVDs, ultimately improving patient outcomes and enhancing healthcare efficiency.

Segmentation by Application

  • Cardiology
  • Pulmonology
  • Neurology
  • Others

INSIGHTS BY CLINICAL PRACTICE

The diagnostic clinical practice segment held the most prominent share of the global digital biomarkers market, accounting for over 34% in 2023. Diagnostic digital biomarkers are increasingly utilized to identify specific diseases, disorders, or physiological conditions through digital data analysis. This could involve patterns in biometric data, imaging, or other digital health inputs. Monitoring digital biomarkers involves the real-time or periodic assessment of digital data to track changes in health status, disease progression, or treatment response. Wearable devices and continuous monitoring platforms are often used. Predictive digital biomarkers help anticipate specific health events, guiding preventive measures or interventions. Predictive digital biomarkers are valuable in identifying at-risk populations.

Segmentation by Clinical Practice

  • Diagnostic
  • Monitoring
  • Prognostic
  • Predictive
  • Others

INSIGHTS BY END-USERS

The global digital biomarkers market by end-user is segmented into healthcare companies, healthcare providers, and others. The healthcare companies segment held the most significant global market share in 2023. In the modern era of healthcare, integrating technology and data-driven solutions has revolutionized patient care, disease management, and drug development. Digital biomarkers, a novel concept in the field of healthcare, have gained prominence as a valuable tool for monitoring and diagnosing various medical conditions. Healthcare companies, including pharmaceutical firms and health tech startups, are increasingly recognizing the potential of digital biomarkers to improve patient outcomes and reduce costs. Another significant advantage of digital biomarkers is their potential to reduce healthcare costs. By adopting digital monitoring tools, healthcare companies can decrease the need for frequent in-person visits and hospital admissions.

Segmentation by End-users

  • Healthcare Companies
  • Healthcare Providers
  • Others

GEOGRAPHICAL ANALYSIS

North America dominated the global digital biomarkers market share, accounting for over 46% in 2023. The market in North America is witnessing remarkable growth and innovation, driven by advancements in technology, a growing emphasis on personalized healthcare, and the increasing adoption of wearable devices and digital health solutions. Factors such as an aging population, increasing healthcare costs, and a shift towards value-based care have driven the adoption of digital biomarkers. Additionally, the COVID-19 pandemic accelerated the acceptance of remote monitoring and telehealth, further boosting the industry's growth.

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • South Africa

VENDOR LANDSCAPE

The global digital biomarkers market is experiencing rapid growth, revolutionizing the healthcare industry by incorporating technology to collect, analyze, and interpret various digital health data. As vendors strive to develop more accurate and effective digital biomarkers, healthcare professionals gain access to advanced tools for diagnosing and managing multiple medical conditions. Ultimately, this contributes to improved patient outcomes and a more efficient healthcare system. Data privacy and security have become paramount with the increasing amount of personal health data collected. Companies that can offer robust security measures and maintain the trust of their users will have a competitive edge.

Key Company Profiles

  • ActiGraph
  • AliveCor
  • Amgen
  • Biogen
  • Koneksa Health

Other Prominent Vendors

  • Adherium
  • Aural Analytics
  • Biofourmis
  • Clario
  • Empatica
  • Feel Therapeutics
  • Gero.ai
  • IXICO
  • Obvio Health
  • Owkin
  • Precordior
  • ResApp Health
  • Rockley Photonics
  • Sonde Health
  • VivoSense

KEY QUESTIONS ANSWERED:

1. How big is the digital biomarkers market?

2. What is the growth rate of the global digital biomarkers market?

3. Which region dominates the global digital biomarkers market share?

4. What are the significant trends in the digital biomarkers industry?

5. Who are the key players in the global digital biomarkers market?

TABLE OF CONTENTS

1 SCOPE & COVERAGE

  • 1.1. MARKET DEFINITION
    • 1.1.1. INCLUSIONS
    • 1.1.2. EXCLUSIONS
    • 1.1.3. MARKET ESTIMATION CAVEATS
  • 1.2. MARKET BY SEGMENTATION
    • 1.2.1. MARKET BY PRODUCT TYPE
    • 1.2.2. MARKET BY APPLICATION
    • 1.2.3. MARKET BY CLINICAL PRACTICE
    • 1.2.4. MARKET BY END-USER
    • 1.2.5. MARKET SEGMENTATIONS COVERED
    • 1.2.6. REGIONS & COUNTRIES COVERED
    • 1.2.7. BASE YEAR
  • 1.3. MARKET DERIVATION

2 PREMIUM INSIGHTS

  • 2.1 OPPORTUNITY POCKETS
  • 2.2 MARKET OPPORTUNITY BY GEOGRAPHY
  • 2.3 MARKET OPPORTUNITY BY PRODUCT TYPE
  • 2.4 MARKET OPPORTUNITY BY APPLICATION
  • 2.5 MARKET OPPORTUNITY BY CLINICAL PRACTICE
  • 2.6 MARKET OPPORTUNITY BY END-USER
  • 2.7 OVERVIEW
  • 2.8 GEOGRAPHY INSIGHTS
  • 2.9 PRODUCT INSIGHTS
  • 2.10 APPLICATION INSIGHTS
  • 2.11 CLINICAL PRACTICE INSIGHTS
  • 2.12 END-USER INSIGHTS

3 MARKET AT A GLANCE

4 INTRODUCTION

  • 4.1 OVERVIEW

5 MARKET OPPORTUNITIES & TRENDS

  • 5.1 RISE IN DIGITIZED VIRTUAL CLINICAL RESEARCH
  • 5.2 INCREASING FOCUS ON DRUG DEVELOPMENT USING DIGITAL BIOMARKERS
  • 5.3 EXPANDING APPLICATIONS OF DIGITAL BIOMARKERS IN MENTAL HEALTH
  • 5.4 GROWING COLLABORATIONS & PARTNERSHIPS AMONG VENDORS

6 MARKET GROWTH ENABLERS

  • 6.1 RISE IN AGING POPULATION & PREVALENCE OF CHRONIC DISEASES
  • 6.2 ADVANCES IN REMOTE PATIENT MONITORING
  • 6.3 GROWING CULTURE OF DIGITAL HEALTH & SHIFT TOWARD OUTPATIENT CARE
  • 6.4 GROWING USE OF WIRELESS & WEARABLE DIGITAL MONITORING TECHNOLOGIES

7 MARKET RESTRAINTS

  • 7.1 DATA SECURITY & PRIVACY CONCERN
  • 7.2 LOW ADOPTION RATE
  • 7.3 LACK OF REGULATORY STANDARDIZATION

8 MARKET LANDSCAPE

  • 8.1 MARKET OVERVIEW
  • 8.2 MARKET SIZE & FORECAST
  • 8.3 FIVE FORCES ANALYSIS
    • 8.3.1 THREAT OF NEW ENTRANTS
    • 8.3.2 BARGAINING POWER OF SUPPLIERS
    • 8.3.3 BARGAINING POWER OF BUYERS
    • 8.3.4 THREAT OF SUBSTITUTES
    • 8.3.5 COMPETITIVE RIVALRY

9 PRODUCT TYPE

  • 9.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 9.2 MARKET OVERVIEW
  • 9.3 WEARABLES & SENSORS
    • 9.3.1 MARKET OVERVIEW
    • 9.3.2 MARKET SIZE & FORECAST
    • 9.3.3 WEARABLES & SENSORS MARKET BY GEOGRAPHY
  • 9.4 MOBILE APPLICATION & SOFTWARE
    • 9.4.1 MARKET OVERVIEW
    • 9.4.2 MARKET SIZE & FORECAST
    • 9.4.3 MOBILE APPLICATION & SOFTWARE MARKET BY GEOGRAPHY

10 APPLICATION

  • 10.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 10.2 MARKET OVERVIEW
  • 10.3 CARDIOLOGY
    • 10.3.1 MARKET OVERVIEW
    • 10.3.2 MARKET SIZE & FORECAST
    • 10.3.3 CARDIOLOGY MARKET BY GEOGRAPHY
  • 10.4 PULMONOLOGY
    • 10.4.1 MARKET OVERVIEW
    • 10.4.2 MARKET SIZE & FORECAST
    • 10.4.3 PULMONOLOGY MARKET BY GEOGRAPHY
  • 10.5 NEUROLOGY
    • 10.5.1 MARKET OVERVIEW
    • 10.5.2 MARKET SIZE & FORECAST
    • 10.5.3 NEUROLOGY MARKET BY GEOGRAPHY
  • 10.6 OTHER
    • 10.6.1 MARKET OVERVIEW
    • 10.6.2 MARKET SIZE & FORECAST
    • 10.6.3 OTHER MARKET BY GEOGRAPHY

11 CLINICAL PRACTICE

  • 11.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 11.2 MARKET OVERVIEW
  • 11.3 DIAGNOSTIC
    • 11.3.1 MARKET OVERVIEW
    • 11.3.2 MARKET SIZE & FORECAST
    • 11.3.3 DIAGNOSTIC MARKET BY GEOGRAPHY
  • 11.4 MONITORING
    • 11.4.1 MARKET OVERVIEW
    • 11.4.2 MARKET SIZE & FORECAST
    • 11.4.3 MONITORING MARKET BY GEOGRAPHY
  • 11.5 PROGNOSTIC
    • 11.5.1 MARKET OVERVIEW
    • 11.5.2 MARKET SIZE & FORECAST
    • 11.5.3 PROGNOSTIC MARKET BY GEOGRAPHY
  • 11.6 PREDICTIVE
    • 11.6.1 MARKET OVERVIEW
    • 11.6.2 MARKET SIZE & FORECAST
    • 11.6.3 PREDICTIVE MARKET BY GEOGRAPHY
  • 11.7 OTHER
    • 11.7.1 MARKET OVERVIEW
    • 11.7.2 MARKET SIZE & FORECAST
    • 11.7.3 OTHER MARKET BY GEOGRAPHY

12 END-USER

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 HEALTHCARE COMPANIES
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 HEALTHCARE COMPANIES MARKET BY GEOGRAPHY
  • 12.4 HEALTHCARE PROVIDERS
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 HEALTHCARE PROVIDERS MARKET BY GEOGRAPHY
  • 12.5 OTHER
    • 12.5.1 MARKET OVERVIEW
    • 12.5.2 MARKET SIZE & FORECAST
    • 12.5.3 OTHER MARKET BY GEOGRAPHY

13 GEOGRAPHY

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 GEOGRAPHIC OVERVIEW

14 NORTH AMERICA

  • 14.1 MARKET OVERVIEW
  • 14.2 MARKET SIZE & FORECAST
    • 14.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 14.2.2 NORTH AMERICA MARKET BY APPLICATION
    • 14.2.3 NORTH AMERICA MARKET BY CLINICAL PRACTICE
    • 14.2.4 NORTH AMERICA MARKET BY END-USER
  • 14.3 KEY COUNTRIES
  • 14.4 US: MARKET SIZE & FORECAST
  • 14.5 CANADA: MARKET SIZE & FORECAST

15 EUROPE

  • 15.1 MARKET OVERVIEW
  • 15.2 MARKET SIZE & FORECAST
    • 15.2.1 EUROPE MARKET BY PRODUCT TYPE
    • 15.2.2 EUROPE MARKET BY APPLICATION
    • 15.2.3 EUROPE MARKET BY CLINICAL PRACTICE
    • 15.2.4 EUROPE MARKET BY END-USER
  • 15.3 KEY COUNTRIES
  • 15.4 GERMANY: MARKET SIZE & FORECAST
  • 15.5 UK: MARKET SIZE & FORECAST
  • 15.6 FRANCE: MARKET SIZE & FORECAST
  • 15.7 ITALY: MARKET SIZE & FORECAST
  • 15.8 SPAIN: MARKET SIZE & FORECAST
  • 15.9 RUSSIA: MARKET SIZE & FORECAST
  • 15.10 NETHERLANDS: MARKET SIZE & FORECAST

16 APAC

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
    • 16.2.1 APAC MARKET BY PRODUCT TYPE
    • 16.2.2 APAC MARKET BY APPLICATION
    • 16.2.3 APAC MARKET BY CLINICAL PRACTICE
    • 16.2.4 APAC MARKET BY END-USER
  • 16.3 KEY COUNTRIES
  • 16.4 JAPAN: MARKET SIZE & FORECAST
  • 16.5 CHINA: MARKET SIZE & FORECAST
  • 16.6 INDIA: MARKET SIZE & FORECAST
  • 16.7 SOUTH KOREA: MARKET SIZE & FORECAST
  • 16.8 AUSTRALIA: MARKET SIZE & FORECAST

17 LATIN AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
    • 17.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 17.2.2 LATIN AMERICA MARKET BY APPLICATION
    • 17.2.3 LATIN AMERICA MARKET BY CLINICAL PRACTICE
    • 17.2.4 LATIN AMERICA MARKET BY END-USER
  • 17.3 KEY COUNTRIES
  • 17.4 BRAZIL: MARKET SIZE & FORECAST
  • 17.5 MEXICO: MARKET SIZE & FORECAST
  • 17.6 ARGENTINA: MARKET SIZE & FORECAST
  • 17.7 COLOMBIA: MARKET SIZE & FORECAST

18 MIDDLE EAST & AFRICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
    • 18.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
    • 18.2.3 MIDDLE EAST & AFRICA MARKET BY CLINICAL PRACTICE
    • 18.2.4 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 18.3 KEY COUNTRIES
  • 18.4 TURKEY: MARKET SIZE & FORECAST
  • 18.5 SAUDI ARABIA: MARKET SIZE & FORECAST
  • 18.6 UAE: MARKET SIZE & FORECAST
  • 18.7 SOUTH AFRICA: MARKET SIZE & FORECAST

19 COMPETITIVE LANDSCAPE

  • 19.1 COMPETITION OVERVIEW
  • 19.2 MARKET SHARE ANALYSIS
    • 19.2.1 ACTIGRAPH
    • 19.2.2 ALIVECOR
    • 19.2.3 AMGEN
    • 19.2.4 BIOGEN
    • 19.2.5 KONEKSA HEALTH

20 KEY COMPANY PROFILES

  • 20.1 ACTIGRAPH
    • 20.1.1 BUSINESS OVERVIEW
    • 20.1.2 PRODUCT OFFERINGS
    • 20.1.3 KEY STRATEGIES
    • 20.1.4 KEY STRENGTHS
    • 20.1.5 KEY OPPORTUNITIES
  • 20.2 ALIVECOR
    • 20.2.1 BUSINESS OVERVIEW
    • 20.2.2 PRODUCT OFFERINGS
    • 20.2.3 KEY STRATEGIES
    • 20.2.4 KEY STRENGTHS
    • 20.2.5 KEY OPPORTUNITIES
  • 20.3 AMGEN
    • 20.3.1 BUSINESS OVERVIEW
    • 20.3.2 PRODUCT OFFERINGS
    • 20.3.3 KEY STRATEGIES
    • 20.3.4 KEY STRENGTHS
    • 20.3.5 KEY OPPORTUNITIES
  • 20.4 BIOGEN
    • 20.4.1 BUSINESS OVERVIEW
    • 20.4.2 PRODUCT OFFERINGS
    • 20.4.3 KEY STRATEGIES
    • 20.4.4 KEY STRENGTHS
    • 20.4.5 KEY OPPORTUNITIES
  • 20.5 KONEKSA HEALTH
    • 20.5.1 BUSINESS OVERVIEW
    • 20.5.2 PRODUCT OFFERINGS
    • 20.5.3 KEY STRATEGIES
    • 20.5.4 KEY STRENGTHS
    • 20.5.5 KEY OPPORTUNITIES

21 OTHER PROMINENT VENDORS

  • 21.1 ADHERIUM
    • 21.1.1 BUSINESS OVERVIEW
    • 21.1.2 PRODUCT OFFERINGS
  • 21.2 AURAL ANALYTICS
    • 21.2.1 BUSINESS OVERVIEW
    • 21.2.2 PRODUCT OFFERINGS
  • 21.3 BIOFOURMIS
    • 21.3.1 BUSINESS OVERVIEW
    • 21.3.2 PRODUCT OFFERINGS
  • 21.4 CLARIO
    • 21.4.1 BUSINESS OVERVIEW
    • 21.4.2 PRODUCT OFFERINGS
  • 21.5 EMPATICA
    • 21.5.1 BUSINESS OVERVIEW
    • 21.5.2 PRODUCT OFFERINGS
  • 21.6 FEEL THERAPEUTICS
    • 21.6.1 BUSINESS OVERVIEW
    • 21.6.2 PRODUCT OFFERINGS
  • 21.7 GERO.AI
    • 21.7.1 BUSINESS OVERVIEW
    • 21.7.2 PRODUCT OFFERINGS
  • 21.8 IXICO
    • 21.8.1 BUSINESS OVERVIEW
    • 21.8.2 PRODUCT OFFERINGS
  • 21.9 OBVIO HEALTH
    • 21.9.1 BUSINESS OVERVIEW
    • 21.9.2 PRODUCT OFFERINGS
  • 21.10 OWKIN
    • 21.10.1 BUSINESS OVERVIEW
    • 21.10.2 PRODUCT OFFERINGS
  • 21.11 PRECORDIOR
    • 21.11.1 BUSINESS OVERVIEW
    • 21.11.2 PRODUCT OFFERINGS
  • 21.12 RESAPP HEALTH
    • 21.12.1 BUSINESS OVERVIEW
    • 21.12.2 PRODUCT OFFERINGS
  • 21.13 ROCKLEY PHOTONICS
    • 21.13.1 BUSINESS OVERVIEW
    • 21.13.2 PRODUCT OFFERINGS
  • 21.14 SONDE HEALTH
    • 21.14.1 BUSINESS OVERVIEW
    • 21.14.2 PRODUCT OFFERINGS
  • 21.15 VIVOSENSE
    • 21.15.1 BUSINESS OVERVIEW
    • 21.15.2 PRODUCT OFFERINGS

22 REPORT SUMMARY

  • 22.1 KEY TAKEAWAYS
  • 22.2 STRATEGIC RECOMMENDATIONS

23 QUANTITATIVE SUMMARY

  • 23.1 MARKET BY PRODUCT TYPE
    • 23.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
    • 23.1.2 EUROPE MARKET BY PRODUCT TYPE
    • 23.1.3 APAC MARKET BY PRODUCT TYPE
    • 23.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
    • 23.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
  • 23.2 MARKET BY APPLICATION
    • 23.2.1 NORTH AMERICA MARKET BY APPLICATION
    • 23.2.2 EUROPE MARKET BY APPLICATION
    • 23.2.3 APAC MARKET BY APPLICATION
    • 23.2.4 LATIN AMERICA MARKET BY APPLICATION
    • 23.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
  • 23.3 MARKET BY CLINICAL PRACTICE
    • 23.3.1 NORTH AMERICA MARKET BY CLINICAL PRACTICE
    • 23.3.2 EUROPE MARKET BY CLINICAL PRACTICE
    • 23.3.3 APAC MARKET BY CLINICAL PRACTICE
    • 23.3.4 LATIN AMERICA MARKET BY CLINICAL PRACTICE
    • 23.3.5 MIDDLE EAST & AFRICA MARKET BY CLINICAL PRACTICE
  • 23.4 MARKET BY END-USER
    • 23.4.1 NORTH AMERICA MARKET BY END-USER
    • 23.4.2 EUROPE MARKET BY END-USER
    • 23.4.3 APAC MARKET BY END-USER
    • 23.4.4 LATIN AMERICA MARKET BY END-USER
    • 23.4.5 MIDDLE EAST & AFRICA MARKET BY END-USER
  • 23.5 MARKET BY GEOGRAPHY
    • 23.5.1 WEARABLES & SENSORS MARKET BY GEOGRAPHY
    • 23.5.2 MOBILE APPLICATION & SOFTWARE MARKET BY GEOGRAPHY
    • 23.5.3 CARDIOLOGY MARKET BY GEOGRAPHY
    • 23.5.4 PULMONOLOGY MARKET BY GEOGRAPHY
    • 23.5.5 NEUROLOGY MARKET BY GEOGRAPHY
    • 23.5.6 OTHER MARKET BY GEOGRAPHY
    • 23.5.7 DIAGNOSTIC MARKET BY GEOGRAPHY
    • 23.5.8 MONITORING MARKET BY GEOGRAPHY
    • 23.5.9 PROGNOSTIC MARKET BY GEOGRAPHY
    • 23.5.10 PREDICTIVE MARKET BY GEOGRAPHY
    • 23.5.11 OTHER MARKET BY GEOGRAPHY
    • 23.5.12 HEALTHCARE COMPANIES MARKET BY GEOGRAPHY
    • 23.5.13 HEALTHCARE PROVIDERS MARKET BY GEOGRAPHY
    • 23.5.14 OTHER MARKET BY GEOGRAPHY

24 APPENDIX

  • 24.1 RESEARCH METHODOLOGY
  • 24.2 RESEARCH PROCESS
  • 24.3 REPORT ASSUMPTIONS & CAVEATS
    • 24.3.1 KEY CAVEATS
    • 24.3.2 CURRENCY CONVERSION
  • 24.4 ABBREVIATIONS